The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Reduction of liver Fas expression by an antisense oligonucleotide protects mice from fulminant hepatitis
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nagata, S., & Golstein, P. (1995) · Science · doi:10.1126/science.7533326 · Cited by 3,979
Lethal effect of the anti-Fas antibody in mice
Ogasawara, J., Watanabe-Fukunaga, R., Adachi, M., Matsuzawa, A., Kasugai, T., Kitamura, Y., Itoh, N., Suda, T., & Nagata, S. (1993) · Nature · doi:10.1038/364806a0 · Cited by 1,881
A T cell-dependent experimental liver injury in mice inducible by concanavalin A.
Tiegs, G., Hentschel, J., & Wendel, A. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115836 · Cited by 1,074
Inhibition of Toxic Epidermal Necrolysis by Blockade of CD95 with Human Intravenous Immunoglobulin
Viard, I., Wehrli, P., Bullani, R., Schneider, P., Holler, N., Salomon, D., Hunziker, T., Saurat, J.-H., Tschopp, J., & French, L. E. (1998) · Science · doi:10.1126/science.282.5388.490 · Cited by 1,005
Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin
(1999) · Transfusion Medicine Reviews · doi:10.1016/s0887-7963(99)80071-6 · Cited by 869
Antisense Research and Applications
Agrawal, S., & Crooke, S. T. (1993) · Medical Entomology and Zoology · Cited by 610
Potential Involvement of Fas and Its Ligand in the Pathogenesis of Hashimoto's Thyroiditis
Giordano, C., Stassi, G., De Maria, R., Todaro, M., Richiusa, P., Papoff, G., Ruberti, G., Bagnasco, M., Testi, R., & Galluzzo, A. (1997) · Science · doi:10.1126/science.275.5302.960 · Cited by 582
Toxic bile salts induce rodent hepatocyte apoptosis via direct activation of Fas
Faubion, W. A., Guicciardi, M. E., Miyoshi, H., Bronk, S. F., Roberts, P. J., Svingen, P. A., Kaufmann, S. H., & Gores, G. J. (1999) · Journal of Clinical Investigation · doi:10.1172/jci4765 · Cited by 536
Essential roles of the Fas ligand in the development of hepatitis
Kondo, T., Suda, T., Fukuyama, H., Adachi, M., & Nagata, S. (1997) · Nature Medicine · doi:10.1038/nm0497-409 · Cited by 479
Tagawa, Y., Sekikawa, K., & Iwakura, Y. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.3.1418 · Cited by 401
Baker, B. F., Lot, S. S., Condon, T. P., Cheng-Flournoy, S., Lesnik, E. A., Sasmor, H. M., & Bennett, C. F. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.18.11994 · Cited by 371
Essential roles of the Fas-Fas ligand pathway in the development of pulmonary fibrosis
Kuwano, K., Hagimoto, N., Kawasaki, M., Yatomi, T., Nakamura, N., Nagata, S., Suda, T., Kunitake, R., Maeyama, T., Miyazaki, H., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5628 · Cited by 345
Noiri, E., Peresleni, T., Miller, F., & Goligorsky, M. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118681 · Cited by 343
Dean, N. M., McKay, R., Condon, T. P., & Bennett, C. F. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)34023-1 · Cited by 291
Self-citationStrand, S., Hofmann, W. J., Grambihler, A., Hug, H., Volkmann, M., Otto, G., Wesch, H., Mariani, S. M., Hack, V., Stremmel, W., et al. (1998) · Nature Medicine · doi:10.1038/nm0598-588 · Cited by 278
Rudi, J., Kuck, D., Strand, S., von Herbay, A., Mariani, S. M., Krammer, P. H., Galle, P. R., & Stremmel, W. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2808 · Cited by 252
CD95 (APO-1/Fas)-mediated apoptosis in colon epithelial cells: A possible role in ulcerative colitis
Strater, J., Wellisch, I., Riedl, S., Walczak, H., Koretz, K., Tandara, A., Krammer, P., & Moller, P. (1997) · Gastroenterology · doi:10.1016/s0016-5085(97)70091-x · Cited by 245
Fas and Fas ligand expression in the salivary glands of patients with primary Sjögren's syndrome
Kong, L., Ogawa, N., Nakabayashi, T., Liu, G. T., D'Souza, E., McGuff, H. S., Guerrero, D., Talal, N., & Dang, H. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400113 · Cited by 221
McKay, R. A., Miraglia, L. J., Cummins, L. L., Owens, S. R., Sasmor, H., & Dean, N. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1715 · Cited by 220
Self-citationTaylor, J. K., Zhang, Q. Q., Wyatt, J. R., & Dean, N. M. (1999) · Nature Biotechnology · doi:10.1038/15079 · Cited by 197
Self-citationAfford, S. C., Randhawa, S., Eliopoulos, A. G., Hubscher, S. G., Young, L. S., & Adams, D. H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.441 · Cited by 192
Bennett, C. F., Kornbrust, D., Henry, S., Stecker, K., Howard, R., Cooper, S., Dutson, S., Hall, W., & Jacoby, H. I. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36471-7 · Cited by 190
Self-citationRay, S. D., Mumaw, V. R., Raje, R. R., & Fariss, M. W. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21309-x · Cited by 177
Disparate Roles for TNF-α and Fas Ligand in Concanavalin A-Induced Hepatitis
Ksontini, R., Colagiovanni, D. B., Josephs, M. D., Edwards, C. K., Tannahill, C. L., Solórzano, C. C., Norman, J., Denham, W., Clare-Salzler, M. J., MacKay, S. L. D., et al. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.8.4082 · Cited by 163
Blazka, M. E., Elwell, M. R., Holladay, S. D., Wilson, R. E., & Luster, M. I. (1996) · Toxicologic Pathology · doi:10.1177/019262339602400206 · Cited by 161
Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis.
Ksontini, R., Colagiovanni, D. B., Josephs, M. D., Edwards, C. K., Tannahill, C. L., Solórzano, C. C., Norman, J., Denham, W., Clare-Salzler, M. J., MacKay, S. L., et al. (1998) · PubMed · Cited by 156
Fas antigen expression in liver tissues of patients with chronic hepatitis B
Mochizuki, K., Hayashi, N., Hiramatsu, N., Katayama, K., Kawanishi, Y., Kasahara, A., Fusamoto, H., & Kamada, T. (1996) · Journal of Hepatology · doi:10.1016/s0168-8278(96)80178-4 · Cited by 145
Quantitation of Phosphorothioate Oligonucleotides in Human Plasma
Leeds, J. M., Graham, M. J., Truong, L., & Cummins, L. L. (1996) · Analytical Biochemistry · doi:10.1006/abio.1996.0088 · Cited by 143
Contribution of Fas ligand to T cell-mediated hepatic injury in mice
Seino, K., Kayagaki, N., Takeda, K., Fukao, K., Okumura, K., & Yagita∥, H. (1997) · Gastroenterology · doi:10.1053/gast.1997.v113.pm9322527 · Cited by 142
Antisense oligonucleotide inhibition of hepatitis C virus gene expression in transformed hepatocytes
Hanecak, R., Brown‐Driver, V., Fox, M., Azad, R. F., Furusako, S., Nozaki, C., Ford, C., Sasmor, H. M., & Anderson, K. (1996) · Journal of Virology · doi:10.1128/jvi.70.8.5203-5212.1996 · Cited by 122
CD95-lnduced Apoptosis in Human Liver Disease
Galle, P. R., & Krammer, P. H. (1998) · Seminars in Liver Disease · doi:10.1055/s-2007-1007150 · Cited by 119
Antisense Research and Application
Crooke, S. T. (1998) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-58785-6 · Cited by 109
Fas system and apoptosis in viral hepatitis
Hayashi, N., & Mita, E. (1997) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.1997.tb00504.x · Cited by 100
Geary, R. S., Leeds, J. M., Fitchett, J. R., et al. (1997) · PubMed · Cited by 98
Concanavalin A Induces Perforin–Mediated But Not Fas–Mediated Hepatic Injury
Watanabe, Y., Morita, M., & Akaike, T. (1996) · Hepatology · doi:10.1053/jhep.1996.v24.pm0008781346 · Cited by 97
Dittel, B. N., Merchant, R. M., & Janeway, C. A. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.11.6392 · Cited by 97
Raised plasma soluble Fas and Fas-ligand in alcoholic liver disease
Taïeb, J., Mathurin, P., Poynard, T., Gougerot-Pocidalo, M. A., & Chollet‐Martin, S. (1998) · The Lancet · doi:10.1016/s0140-6736(05)78614-1 · Cited by 82
Stassi, G., Todaro, M., Bucchieri, F., Stoppacciaro, A., Farina, F., Zummo, G., Testi, R., & Maria, R. D. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.1.263 · Cited by 70
Apoptosis Mediated by the Fas System
Nagata, S. (1996) · Progress in molecular and subcellular biology · doi:10.1007/978-3-642-79850-4_6 · Cited by 68
Basic Principles of Antisense Therapeutics
Crooke, S. T. (1998) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-58785-6_1 · Cited by 66
Therapeutic effect of an anti-Fas ligand mAb on lethal graft-versus-host disease
Miwa, K., Hashimoto, H., Yatomi, T., Nakamura, N., Nagata, S., & Suda, T. (1999) · International Immunology · doi:10.1093/intimm/11.6.925 · Cited by 64
Luo, K. X., Zhu, Y. ‐., Zhang, L. ‐., He, H., Wang, X. ‐., & Zhang, L. (1997) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.1997.00053.x · Cited by 52
Pharmacology of Antisense Oligonucleotide Inhibitors of Protein Expression
Cooper, S. R., Taylor, J. K., Miraglia, L. J., & Dean, N. M. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00002-9 · Cited by 35
Self-citationModification of pre-mRNA splicing by antisense oligonucleotides.
Kole, R. (1997) · Acta Biochimica Polonica · doi:10.18388/abp.1997_4418 · Cited by 17
Cited by
RNA interference targeting Fas protects mice from fulminant hepatitis
Song, E., Lee, S.-K., Wang, J., Ince, N., Ouyang, N., Min, J., Chen, J., Shankar, P., & Lieberman, J. (2003) · Nature Medicine · doi:10.1038/nm828 · Cited by 1,110
Idiosyncratic drug hepatotoxicity
Kaplowitz, N. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1750 · Cited by 1,054
Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides
Geary, R. S., Norris, D., Yu, R., & Bennett, C. F. (2015) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.01.008 · Cited by 845
Self-citationAntisense oligonucleotides: the next frontier for treatment of neurological disorders
Rinaldi, C., & Wood, M. J. A. (2018) · Nature Reviews Neurology · doi:10.1038/nrneurol.2017.148 · Cited by 788
Cellular and Molecular Mechanisms of Liver Injury
Malhi, H., & Gores, G. J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.002 · Cited by 560
Metadata
- Authors
- Zhang, H., Cook, J., Nickel, J., Yu, R., Stecker, K., Myers, K., & Dean, N. M.
- Venue
- Nature Biotechnology
- Published
- 2000-08
- Volume
- 18
- Issue
- 8
- Pages
- 862-867
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W1988582067
- Cited by
- 268
- References
- 44
- FWCI
- 7.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.